Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c727d0aef5b1f28290f7ccdf941d6ead http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f064ed20ce7e0816854844841fb2bbe3 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-275 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-275 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
filingDate |
2012-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a86c9af77ee2a91696e0e4bf38e5647 |
publicationDate |
2012-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2012162339-A1 |
titleOfInvention |
Use of teriflunomide for reducing occurrence of relapses requiring healthcare resources |
abstract |
The present invention relates to the use of teriflunomide for reducing occurrence of relapses requiring healthcare resources in patients having multiple sclerosis. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2762135-A1 |
priorityDate |
2011-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |